MX2015017129A - Use of leuprolide acetate as a neuro-regenerator. - Google Patents
Use of leuprolide acetate as a neuro-regenerator.Info
- Publication number
- MX2015017129A MX2015017129A MX2015017129A MX2015017129A MX2015017129A MX 2015017129 A MX2015017129 A MX 2015017129A MX 2015017129 A MX2015017129 A MX 2015017129A MX 2015017129 A MX2015017129 A MX 2015017129A MX 2015017129 A MX2015017129 A MX 2015017129A
- Authority
- MX
- Mexico
- Prior art keywords
- leuprolide acetate
- neuro
- regenerator
- pharmaceutically acceptable
- proregenerative
- Prior art date
Links
- 108010000817 Leuprolide Proteins 0.000 title abstract 2
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 title abstract 2
- 229960004338 leuprorelin Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 208000001738 Nervous System Trauma Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 208000028412 nervous system injury Diseases 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 210000000278 spinal cord Anatomy 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present disclosure is related to compositions useful for the treatment of diseases associated with a nervous system injury that is susceptible to a proregenerative environment such as injuries in the spinal cord and brain, inter alia. Said compositions comprise leuprolide acetate and at least one pharmaceutically acceptable carrier and/or a pharmaceutically acceptable excipient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2015017129A MX2015017129A (en) | 2015-12-02 | 2015-12-02 | Use of leuprolide acetate as a neuro-regenerator. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2015017129A MX2015017129A (en) | 2015-12-02 | 2015-12-02 | Use of leuprolide acetate as a neuro-regenerator. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015017129A true MX2015017129A (en) | 2017-06-01 |
Family
ID=59684322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015017129A MX2015017129A (en) | 2015-12-02 | 2015-12-02 | Use of leuprolide acetate as a neuro-regenerator. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX2015017129A (en) |
-
2015
- 2015-12-02 MX MX2015017129A patent/MX2015017129A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201708692B (en) | Antibacterial compounds | |
| MX2017005834A (en) | Aadc polynucleotides for the treatment of parkinson's disease. | |
| MX2021000071A (en) | Use of pridopidine to improve cognitive function and for treating alzheimer's disease. | |
| MX2022009155A (en) | Novel polymeric hgh prodrugs. | |
| WO2016040952A3 (en) | BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS | |
| PH12017500401A1 (en) | Therapeutic compounds as inhibitors of the orexin-1 receptor | |
| MX2017006437A (en) | Spiro-isoquinoline-1,4'-piperidine compounds having multimodal activity against pain. | |
| EA201691567A1 (en) | METHODS OF TREATING PULMONARY INJURIES TO THE BRAIN | |
| MY208313A (en) | Compositions and methods for treating brain injury | |
| MX2019000677A (en) | B-cell-mimetic cells. | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| MX2017014456A (en) | THERAPEUTIC USES OF L-4-CHLOROQUINURENINE. | |
| GB201710822D0 (en) | Methods and medical uses relating to the treatment of hypoglycaemia | |
| MX2020009966A (en) | Dosage forms and therapeutic uses l-4-chlorokynurenine. | |
| MX364528B (en) | Withanolides useful for the treatment of neurodegenerative diseases. | |
| MX380758B (en) | COMPOUND HAVING MUTANT HDI INHIBITORY ACTIVITY, METHOD OF PREPARATION AND USES THEREOF. | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| PT3829579T (en) | 1,3,8-triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury | |
| MX2015017129A (en) | Use of leuprolide acetate as a neuro-regenerator. | |
| PH12016502107A1 (en) | Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders | |
| EP3253311A4 (en) | Scaffolds for the treatment of spinal cord injuries and diseases | |
| MX2015009505A (en) | In vitro antimicrobial activity from the combination of scorpion anti-biocidal peptides with common use antibiotics. | |
| HK1242961A (en) | Protective metallothionein analog compounds, their compositions and use thereof in the treatment of pathogenic diseases | |
| HK1242961A1 (en) | Protective metallothionein analog compounds, their compositions and use thereof in the treatment of pathogenic diseases | |
| MX2016010919A (en) | 4-benzylsulfonyl-2-butenenitrile. |